Immuneering
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -175 | -187 | ||
EBITDA | -18,465 | -15,177 | -14,815 | -15,228 |
EBIT | -18,558 | -15,273 | -14,913 | -15,415 |
Net Income | -18,051 | -14,597 | -14,079 | -14,307 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,519 | -13,477 | -11,558 | -15,528 |
Cash | 36,144 | 45,205 | 59,728 | 66,287 |
Basic Shares | 29,981 | 29,841 | 29,653 | 29,370 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $ | $316 | $2,079 |
Gross Profit | -764 | 158 | 926 | |
EBITDA | -64,071,401 | -58,060 | -51,467 | -33,726 |
EBIT | -58,412 | -52,264 | -33,886 | |
Net Income | -61,036,608 | -53,471 | -49,281 | -33,535 |
Net Change In Cash | 0 | 316 | 2,079 | |
Cost of Revenue | -2,251 | 37,797 | ||
Free Cash Flow | -55,084 | -49,311 | -44,843 | -30,911 |
Cash | 36,144,720 | 59,405 | 72,636 | 74,888 |
Basic Shares | 29,981 | 28,416 | 26,386 | 26,320 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.58 |
2024-09-30 | -$0.49 |
2024-06-30 | -$0.47 |
2024-03-31 | -$0.49 |
